Cancer Research Annual Meeting 2010 Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, Y.
Right arrow Articles by Wu, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, Y.
Right arrow Articles by Wu, X.
[Cancer Research 61, 7825-7829, November 1, 2001]
© 2001 American Association for Cancer Research

Epidemiology and Prevention

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility1

Yong Zhu, Margaret R. Spitz, Lei Lei, Gordon B. Mills and Xifeng Wu2

Departments of Epidemiology [Y. Z., M. R. S., L. L., X. W.] and Molecular Therapeutics [G. B. M.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Extracellular matrix-degrading matrix metalloproteinase-1 (MMP-1) is one of the interstitial collagenases likely to be involved in tumor invasion and metastasis. MMP-1 may also contribute to tumor initiation and development by altering the cellular microenvironment that facilitates tumor formation. Recent studies have found that overexpression of MMP-1 is associated with the initial stages of cancer development in addition to promoting cellular invasion; however, preexisting oncogenic mutations or chemical carcinogens are required to initiate tumorigenesis as well. There is a single nucleotide polymorphism located in the promoter region of MMP-1 that partially regulates gene expression. The 2G/2G genotype enhances transcriptional activity and may be associated with an increased lung cancer risk. Using a case-control study, we tested the hypotheses that (a) individuals with the 2G/2G genotype may be at an increased risk for lung cancer; and (b) the risk should be greatly elevated in smoking individuals. PCR-RFLP was used to determine the MMP-1 genotypes in 456 lung-cancer cases and 451 frequency-matched controls of Caucasian ethnicity. Overall, there was a significant association between the 2G/2G genotype and lung cancer risk [odds ratio (OR), 1.76; 95% confidence interval (CI), 1.29–2.39]. In current smokers, the lung cancer risk associated with the 2G/2G genotype was significantly elevated (OR, 3 .16; 95% CI, 1.87–5.35). However, this association was less evident in former smokers (OR, 1.23; 95% CI, 0.81–1.87) and absent in never smokers (OR, 1.09; 95% CI, 0.31–3.91). Similarly, this risk was more evident in heavy smokers (OR, 2.55; 95% CI, 1.61–4.03) than in light smokers (OR, 1.40; 95% CI, 0.84–2.32). Interestingly, men were observed to have a 2.15-fold increased lung cancer risk (OR, 2.15; 95% CI, 1.42–3.26) compared with women (OR, 1.34; 95% CI, 0.84–2.15). Furthermore, subjects with 2G/2G genotype developed lung cancer earlier (60.94 ± 0.64 years old) than patients with 1G/1G and 1G/2G genotypes (62.91 ± 0.59 years old; P = 0.024). Our data demonstrate that the 2G/2G genotype enhances lung cancer susceptibility especially in current smokers. To our knowledge, these results report the first molecular epidemiological evidence of the MMP-1 promoter polymorphism associated with the development of lung cancer in the presence of continuing carcinogenic exposure.




This article has been cited by other articles:


Home page
 Eur Respir JHome page
D. B. Scherf, H. Dally, P. Muller, G. Werle-Schneider, B. Jager, L. Edler, S. Tuengerthal, J. R. Fischer, P. Drings, H. Bartsch, et al.
Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis
Eur. Respir. J., February 1, 2010; 35(2): 381 - 390.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
B. Peng, L. Cao, W. Wang, L. Xian, D. Jiang, J. Zhao, Z. Zhang, X. Wang, and L. Yu
Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies
Mutagenesis, January 1, 2010; 25(1): 41 - 48.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
P. A. Bradbury, R. Zhai, J. Hopkins, M. H. Kulke, R. S. Heist, S. Singh, W. Zhou, C. Ma, W. Xu, K. Asomaning, et al.
Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis
Carcinogenesis, May 1, 2009; 30(5): 793 - 798.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
B. A. Mercer, A. M. Wallace, C. E. Brinckerhoff, and J. M. D'Armiento
Identification of a Cigarette Smoke-Responsive Region in the Distal MMP-1 Promoter
Am. J. Respir. Cell Mol. Biol., January 1, 2009; 40(1): 4 - 12.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
W. Sauter, A. Rosenberger, L. Beckmann, S. Kropp, K. Mittelstrass, M. Timofeeva, G. Wolke, A. Steinwachs, D. Scheiner, E. Meese, et al.
Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer
Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1127 - 1135.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Decock, J.-R. Long, R. C. Laxton, X.-O. Shu, C. Hodgkinson, W. Hendrickx, E. G. Pearce, Y.-T. Gao, A. C. Pereira, R. Paridaens, et al.
Association of Matrix Metalloproteinase-8 Gene Variation with Breast Cancer Prognosis
Cancer Res., November 1, 2007; 67(21): 10214 - 10221.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W. K. Steagall, C. G. Glasgow, O. M. Hathaway, N. A. Avila, A. M. Taveira-DaSilva, A. Rabel, M. P. Stylianou, J.-P. Lin, X. Chen, and J. Moss
Genetic and morphologic determinants of pneumothorax in lymphangioleiomyomatosis
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L800 - L808.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
L. Milani, M. Gupta, M. Andersen, S. Dhar, M. Fryknas, A. Isaksson, R. Larsson, and A.-C. Syvanen
Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells
Nucleic Acids Res., March 12, 2007; 35(5): e34 - e34.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
E. G. Pearce, R. C. Laxton, A. C. Pereira, and S. Ye
Haplotype Effects on Matrix Metalloproteinase-1 Gene Promoter Activity in Cancer Cells
Mol. Cancer Res., March 1, 2007; 5(3): 221 - 227.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Sun, Y. Gao, W. Tan, S. Ma, X. Zhang, Y. Wang, Q. Zhang, Y. Guo, D. Zhao, C. Zeng, et al.
Haplotypes in Matrix Metalloproteinase Gene Cluster on Chromosome 11q22 Contribute to the Risk of Lung Cancer Development and Progression
Clin. Cancer Res., December 1, 2006; 12(23): 7009 - 7017.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
M. Sugimoto, S. Yoshida, S. Kennedy, M. Deguchi, N. Ohara, and T. Maruo
Matrix Metalloproteinase-1 and -9 Promoter Polymorphisms and Endometrial Carcinoma Risk in a Japanese Population
Reproductive Sciences, October 1, 2006; 13(7): 523 - 529.
[Abstract] [PDF]

Home page
 J Gerontol A Biol Sci Med SciHome page
A. Flex, E. Gaetani, A. S. Proia, G. Pecorini, G. Straface, F. Biscetti, G. Fioroni, A. Sabusco, R. Flore, P. Tondi, et al.
Analysis of Functional Polymorphisms of Metalloproteinase Genes in Persons With Vascular Dementia and Alzheimer's Disease
J Gerontol A Biol Sci Med Sci, October 1, 2006; 61(10): 1065 - 1069.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. S. Heist, A. L. Marshall, G. Liu, W. Zhou, L. Su, D. Neuberg, T. J. Lynch, J. Wain, and D. C. Christiani
Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer.
Clin. Cancer Res., September 15, 2006; 12(18): 5448 - 5453.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. K. Nelson, S. Subbaram, K. M. Connor, J. Dasgupta, X.-F. Ha, T.-C. Meng, N. K. Tonks, and J. A. Melendez
Redox-dependent Matrix Metalloproteinase-1 Expression Is Regulated by JNK through Ets and AP-1 Promoter Motifs
J. Biol. Chem., May 19, 2006; 281(20): 14100 - 14110.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
L. Su, W. Zhou, K. Asomaning, X. Lin, J. C. Wain, T. J. Lynch, G. Liu, and D. C. Christiani
Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer
Carcinogenesis, May 1, 2006; 27(5): 1024 - 1029.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
N. Takemura, S. Yoshida, S. Kennedy, M. Deguchi, N. Ohara, and T. Maruo
Matrix Metalloproteinase-1 and -9 Promoter Polymorphisms Are Not Associated With an Increased Risk of Uterine Leiomyomas in a Japanese Population
Reproductive Sciences, April 1, 2006; 13(3): 232 - 236.
[Abstract] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. G. Schwartz and J. C. Ruckdeschel
Familial Lung Cancer: Genetic Susceptibility and Relationship to Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 16 - 22.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
T. Xiao, W. Ying, L. Li, Z. Hu, Y. Ma, L. Jiao, J. Ma, Y. Cai, D. Lin, S. Guo, et al.
An Approach to Studying Lung Cancer-related Proteins in Human Blood
Mol. Cell. Proteomics, October 1, 2005; 4(10): 1480 - 1486.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
K. Shan, W. Ying, Z. Jian-Hui, G. Wei, W. Na, and L. Yan
The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China
Mol. Hum. Reprod., June 1, 2005; 11(6): 423 - 427.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y. Zhou, C. Yu, X. Miao, Y. Wang, W. Tan, T. Sun, X. Zhang, P. Xiong, and D. Lin
Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility
Carcinogenesis, June 1, 2005; 26(6): 1117 - 1121.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. Su, W. Zhou, S. Park, J. C. Wain, T. J. Lynch, G. Liu, and D. C. Christiani
Matrix Metalloproteinase-1 Promoter Polymorphism and Lung Cancer Risk
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 567 - 570.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
M. B. Schabath, G. L. Delclos, M. M. Martynowicz, A. J. Greisinger, C. Lu, X. Wu, and M. R. Spitz
Opposing Effects of Emphysema, Hay Fever, and Select Genetic Variants on Lung Cancer Risk
Am. J. Epidemiol., March 1, 2005; 161(5): 412 - 422.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Fang, X. Jin, R. Wang, Y. Li, W. Guo, N. Wang, Y. Wang, D. Wen, L. Wei, and J. Zhang
Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China
Carcinogenesis, February 1, 2005; 26(2): 481 - 486.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Zinzindohoue, T. Lecomte, J.-M. Ferraz, A.-M. Houllier, P.-H. Cugnenc, A. Berger, H. Blons, and P. Laurent-Puig
Prognostic Significance of MMP-1 and MMP-3 Functional Promoter Polymorphisms in Colorectal Cancer
Clin. Cancer Res., January 15, 2005; 11(2): 594 - 599.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. R. Spitz, X. Wu, and G. Mills
Integrative Epidemiology: From Risk Assessment to Outcome Prediction
J. Clin. Oncol., January 10, 2005; 23(2): 267 - 275.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Jia, Z.-Z. Zeng, S. M. Markwart, K. F. Rockwood, K. M. W. Ignatoski, S. P. Ethier, and D. L. Livant
Integrin Fibronectin Receptors in Matrix Metalloproteinase-1-Dependent Invasion by Breast Cancer and Mammary Epithelial Cells
Cancer Res., December 1, 2004; 64(23): 8674 - 8681.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H. Hirata, N. Okayama, K. Naito, R. Inoue, S. Yoshihiro, H. Matsuyama, Y. Suehiro, Y. Hamanaka, and Y. Hinoda
Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma
Carcinogenesis, December 1, 2004; 25(12): 2379 - 2384.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y.-C. Fong, C. M. Dutton, S. S. Cha, N. Garamszegi, F. H. Sim, and S. P. Scully
Absence of a Correlation between the Presence of a Single Nucleotide Polymorphism in the Matrix Metalloproteinase 1 Promoter and Outcome in Patients of Chondrosarcoma
Clin. Cancer Res., November 1, 2004; 10(21): 7329 - 7334.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Yu, Y. Zhou, X. Miao, P. Xiong, W. Tan, and D. Lin
Functional Haplotypes in the Promoter of Matrix Metalloproteinase-2 Predict Risk of the Occurrence and Metastasis of Esophageal Cancer
Cancer Res., October 15, 2004; 64(20): 7622 - 7628.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Blons, S. Gad, F. Zinzindohoue, I. Maniere, J. Beauregard, D. Tregouet, D. Brasnu, P. Beaune, O. Laccourreye, and P. Laurent-Puig
Matrix Metalloproteinase 3 Polymorphism: A Predictive Factor of Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., April 15, 2004; 10(8): 2594 - 2599.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Listgarten, S. Damaraju, B. Poulin, L. Cook, J. Dufour, A. Driga, J. Mackey, D. Wishart, R. Greiner, and B. Zanke
Predictive Models for Breast Cancer Susceptibility from Multiple Single Nucleotide Polymorphisms
Clin. Cancer Res., April 15, 2004; 10(8): 2725 - 2737.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y. Zhou, C. Yu, X. Miao, W. Tan, G. Liang, P. Xiong, T. Sun, and D. Lin
Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes
Carcinogenesis, March 1, 2004; 25(3): 399 - 404.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. Ghilardi, M. L. Biondi, M. Erario, E. Guagnellini, and R. Scorza
Colorectal Carcinoma Susceptibility and Metastases Are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms
Clin. Chem., November 1, 2003; 49(11): 1940 - 1942.
[Full Text] [PDF]

Home page
 Reproductive SciencesHome page
R. M. Wenham, B. Calingaert, S. Ali, K. McClean, R. Whitaker, R. Bentley, J. M. Lancaster, J. Schildkraut, J. Marks, and A. Berchuck
Matrix Metalloproteinase-1 Gene Promoter Polymorphism and Risk of Ovarian Cancer
Reproductive Sciences, September 1, 2003; 10(6): 381 - 387.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
X. Miao, C. Yu, W. Tan, P. Xiong, G. Liang, W. Lu, and D. Lin
A Functional Polymorphism in the Matrix Metalloproteinase-2 Gene Promoter (-1306C/T) Is Associated with Risk of Development but not Metastasis of Gastric Cardia Adenocarcinoma
Cancer Res., July 15, 2003; 63(14): 3987 - 3990.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. L. Degg, M. M. Weil, A. Edwards, J. Haines, M. Coster, J. Moody, M. Ellender, R. Cox, and A. Silver
Adenoma Multiplicity in Irradiated ApcMin Mice Is Modified by Chromosome 16 Segments from BALB/c
Cancer Res., May 15, 2003; 63(10): 2361 - 2363.
[Abstract] [Full Text] [PDF]

Home page
 Plant Physiol.Home page
F. Thibaud-Nissen, R. T. Shealy, A. Khanna, and L. O. Vodkin
Clustering of Microarray Data Reveals Transcript Patterns Associated with Somatic Embryogenesis in Soybean
Plant Physiology, May 1, 2003; 132(1): 118 - 136.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. A. Wyatt, C. I. Coon, J. J. Gibson, and C. E. Brinckerhoff
Potential for the 2G Single Nucleotide Polymorphism in the Promoter of Matrix Metalloproteinase to Enhance Gene Expression in Normal Stromal Cells
Cancer Res., December 15, 2002; 62(24): 7200 - 7202.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Ghilardi, M. L. Biondi, M. Caputo, S. Leviti, M. DeMonti, E. Guagnellini, and R. Scorza
A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-3 Promoter Enhances Breast Cancer Susceptibility
Clin. Cancer Res., December 1, 2002; 8(12): 3820 - 3823.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Yu, K. Pan, D. Xing, G. Liang, W. Tan, L. Zhang, and D. Lin
Correlation between a Single Nucleotide Polymorphism in the Matrix Metalloproteinase-2 Promoter and Risk of Lung Cancer
Cancer Res., November 15, 2002; 62(22): 6430 - 6433.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.